Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs.
about
In vitro and in vivo effects of doxycycline on Toxoplasma gondiiCritical data-based re-evaluation of minocycline as a putative specific microglia inhibitor.Survival of treponemes after treatment: comments, clinical conclusions, and recommendations.Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemiaPharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials.Pharmacokinetics of doxycycline in dogs.Anatomical barriers for antimicrobial agents.Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis.Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine.Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis.Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis.Role of oxygen radicals in the phototoxicity of tetracyclines toward Escherichia coli BSide effects of minocycline: a double-blind study.Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosisMinocycline: far beyond an antibiotic.Chronic oral administration of minocycline to sheep with ovine CLN6 neuronal ceroid lipofuscinosis maintains pharmacological concentrations in the brain but does not suppress neuroinflammation or disease progressionCNS inflammation and bone marrow neuropathy in type 1 diabetes.Agents for the decolonization of methicillin-resistant Staphylococcus aureus.Minocycline attenuates iron neurotoxicity in cortical cell cultures.Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs.Managing Rocky Mountain spotted fever.Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature.Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action.The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke.Update in feline therapeutics: clinical use of 10 emerging therapies.Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus.Modern neurosyphilis: a partially treated chronic meningitis.Effect of tetracyclines and UV light on oxygen consumption by human leukocytesRationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis.Bacterial resistance to the tetracyclines.Cetocycline, tetracycline analog: in vitro studies of antimicrobial activity, serum binding, lipid solubility, and uptake by bacteria.Pharmacokinetics of minocycline in domestic cats.Susceptibility to antimicrobials of mastitis-causing Staphylococcus aureus, Streptococcus uberis and Str. dysgalactiae from New Zealand and the USA as assessed by the disk diffusion test.Pharmacodynamics of doxycycline and tetracycline against Staphylococcus pseudintermedius: proposal of canine-specific breakpoints for doxycycline.The effect of doxycycline hyclate, chlorhexidine gluconate, and minocycline hydrochloride on osteoblastic proliferation and differentiation in vitro.Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes.Pain in amyotrophic lateral sclerosis: a neglected aspect of diseaseInfluence of tetracyclines on human polymorphonuclear leukocyte function.Antipsychotic-like effect of minocycline in a rat model.Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation.
P2860
Q28335472-EAC14A1F-4AF3-4534-9132-C426FAACC135Q31104505-A007A0D1-3E01-4FDC-8A66-BFE3A682778DQ33582904-DADE4D5E-399B-4475-B9C1-F673E45E857FQ33612679-D57D3ACF-E3CA-4C0C-8084-50E68F1D7D65Q33693467-B7C356F6-87F3-4098-86B9-AF7D5C3E299CQ34080693-92A84EF6-5F33-4267-9FC3-E51773235FD2Q34363796-BA665F84-9CA2-4964-A952-AEE35DA1811DQ34454263-045282CB-774F-45BF-BA26-06A585FEECFCQ34574117-F9816B2D-0B34-4E14-8F76-63B861C7A16DQ35566456-C5F7F9B0-8E70-452E-BF92-E02256400606Q35646489-7C2D2DD6-6BEA-4A5C-BA4E-2255E2136B42Q36237733-FBEBF71E-B313-47FB-9066-B1C22159EA95Q36462191-009DC6F3-239C-4B12-98C3-ED231705A1CEQ36758482-0B95D8F6-FEE3-4303-884F-4835B0410F65Q36836358-6B2B548E-697B-4E37-9151-D7A54D30BA0FQ37071340-D4EBFF03-7421-4D03-B95C-B0908B8E6756Q37271493-4B7AADB0-6140-401C-9C8E-A0D6E7CB9874Q37403450-ADA589E8-C3CB-4111-87B2-C85FD93ECD04Q37436917-D23B9CCC-DE20-4AF3-99E0-F10363801EE3Q37437540-52C708D9-34CD-4BC0-B883-05350A27028FQ37626073-E3BB85B5-1996-44E6-98F1-F49BBA5B2BF0Q37769021-852B6B13-02DB-4502-B6B0-D8105C3EFADDQ37800572-3DDDFE05-0AD2-4528-9F22-528C3DC3F7F5Q38168582-30875243-15AC-44E7-A949-974C0BE77BBCQ38363411-CCF00DF5-E3C3-4F19-B354-E8DDD92F85F5Q39338873-5356FDE9-2563-4AB0-9054-6C9F313DAB0BQ39365979-B0C2C091-5D62-4142-8F43-F09AD18E0706Q39849049-2E310BD8-46E6-40C9-9F30-F5D820562DC2Q40200463-7E933D2C-E233-4D2E-AF16-A93A72BD877AQ40270651-121F1E2B-5F77-4D79-A02F-524FC9FE2ECDQ40618328-735EBD93-39CB-42D8-9796-BCE760217333Q41104042-8E25B832-37CC-4A77-BFB2-B725B5E996ADQ41138894-560FC061-58CD-488F-B94A-8FFCB2616C54Q41827471-C4345661-4068-4A89-839A-A0A33C327876Q41996160-7B706AD1-B1A1-4AF0-AF0A-6575808B59CBQ42111691-CC06F7B1-F8BE-400E-90A0-D175848D12E1Q42797616-3CA70AF6-7E48-41FC-93DC-2942F7AEB000Q42929792-3AC64F86-8782-4807-A7FE-60FF167C7F0CQ43015622-5841FB41-1392-4600-9947-CE7E4E2449B6Q43752350-0587FB13-102A-4DB4-9E84-7BB5FC018C14
P2860
Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Relation between lipophilicity ...... , and oxytetracycline in dogs.
@en
type
label
Relation between lipophilicity ...... , and oxytetracycline in dogs.
@en
prefLabel
Relation between lipophilicity ...... , and oxytetracycline in dogs.
@en
P2093
P2860
P356
P1476
Relation between lipophilicity ...... , and oxytetracycline in dogs.
@en
P2093
P2860
P304
P356
10.1128/AAC.8.6.713
P407
P577
1975-12-01T00:00:00Z